4.2 Article Proceedings Paper

Can estrogens promote hypertension during systemic lupus erythematosus?

Journal

STEROIDS
Volume 75, Issue 11, Pages 766-771

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2010.02.010

Keywords

Lupus; Estrogen; Hypertension; Immune; Hormone; Inflammation

Funding

  1. NHLBI NIH HHS [K02 HL092284, HL092284, HL085907, R01 HL085907, HL085907S3] Funding Source: Medline

Ask authors/readers for more resources

SLE is a chronic autoimmune inflammatory disorder that predominantly affects young women. Based on this observation, it has been speculated that sex steroids, particularly estrogens, contribute to SLE disease progression. Young women with SLE are at an increased risk for the development of hypertension yet the reasons for this are unclear. One potential mechanism for the increased risk of hypertension during SLE is the chronic inflammation caused by immune complex mediated tissue injury. Estrogens are known to have an immunomodulatory role that can lead to the production of characteristic autoantibodies important for immune complex formation. Therefore, it is conceivable that during SLE estrogens contribute to tissue injury, increased inflammation and hypertension. This brief review discusses the increased risk for hypertension during SLE, the role of estrogens in immune system function, evidence for estrogens in SLE, and a possible link between estrogens and SLE hypertension. (C) 2010 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available